207 related articles for article (PubMed ID: 38393358)
21. Acupuncture and acupressure for premenstrual syndrome.
Armour M; Ee CC; Hao J; Wilson TM; Yao SS; Smith CA
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005290. PubMed ID: 30105749
[TBL] [Abstract][Full Text] [Related]
22. [Premenstrual dysphoric disorder is often overlooked].
Reveles Jensen KH; Sinclair K
Ugeskr Laeger; 2018 Nov; 180(47):. PubMed ID: 30509347
[TBL] [Abstract][Full Text] [Related]
23. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder.
Sundström-Poromaa I; Comasco E
CNS Drugs; 2023 May; 37(5):371-379. PubMed ID: 37171547
[TBL] [Abstract][Full Text] [Related]
24. Treatment of premenstrual dysphoric disorder.
Rapkin AJ; Lewis EI
Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
[TBL] [Abstract][Full Text] [Related]
25. Premenstrual Dysphoric Disorder.
Lanza di Scalea T; Pearlstein T
Med Clin North Am; 2019 Jul; 103(4):613-628. PubMed ID: 31078196
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials.
de Wit AE; de Vries YA; de Boer MK; Scheper C; Fokkema A; Janssen CAH; Giltay EJ; Schoevers RA
Am J Obstet Gynecol; 2021 Dec; 225(6):624-633. PubMed ID: 34224688
[TBL] [Abstract][Full Text] [Related]
27. What's Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy.
Wagner-Schuman M; Kania A; Barone JC; Ross JM; Mulvihill A; Eisenlohr-Moul TA
J Clin Psychiatry; 2023 Jun; 84(4):. PubMed ID: 37341478
[No Abstract] [Full Text] [Related]
28. Premenstrual syndrome and premenstrual dysphoric disorder.
Biggs WS; Demuth RH
Am Fam Physician; 2011 Oct; 84(8):918-24. PubMed ID: 22010771
[TBL] [Abstract][Full Text] [Related]
29. Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder.
Takeda T
J Obstet Gynaecol Res; 2023 Feb; 49(2):510-518. PubMed ID: 36317488
[TBL] [Abstract][Full Text] [Related]
30. Premenstrual Dysphoric Disorder.
Lanza di Scalea T; Pearlstein T
Psychiatr Clin North Am; 2017 Jun; 40(2):201-216. PubMed ID: 28477648
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
[TBL] [Abstract][Full Text] [Related]
32. Unfolding the mystery of premenstrual syndrome (PMS): an overview.
Zehravi M; Maqbool M; Ara I
Int J Adolesc Med Health; 2023 Feb; 35(1):9-13. PubMed ID: 36117244
[TBL] [Abstract][Full Text] [Related]
33. [Premenstrual dysphoric disorder: approach and treatment].
Bianchi-Demicheli F; Lüdicke F; Campana A
Gynecol Obstet Fertil; 2003 Jan; 31(1):49-54. PubMed ID: 12659785
[TBL] [Abstract][Full Text] [Related]
34. Premenstrual Dysphoric Disorder: Contemporary Diagnosis and Management.
Reid RL; Soares CN
J Obstet Gynaecol Can; 2018 Feb; 40(2):215-223. PubMed ID: 29132964
[TBL] [Abstract][Full Text] [Related]
35. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
[TBL] [Abstract][Full Text] [Related]
36. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Brown J; O' Brien PM; Marjoribanks J; Wyatt K
Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
[TBL] [Abstract][Full Text] [Related]
37. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.
Rapkin AJ; Mikacich JA; Moatakef-Imani B; Rasgon N
Curr Psychiatry Rep; 2002 Dec; 4(6):419-28. PubMed ID: 12441021
[TBL] [Abstract][Full Text] [Related]
38. [Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches].
Lenzinger E; Diamant K; Vytiska-Binstorfer E; Kasper S
Nervenarzt; 1997 Sep; 68(9):708-18. PubMed ID: 9411273
[TBL] [Abstract][Full Text] [Related]
39. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
Schmidt PJ; Martinez PE; Nieman LK; Koziol DE; Thompson KD; Schenkel L; Wakim PG; Rubinow DR
Am J Psychiatry; 2017 Oct; 174(10):980-989. PubMed ID: 28427285
[TBL] [Abstract][Full Text] [Related]
40. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
